Close Menu

Xceed Molecular

Under the terms of the deal, Holliston, Mass.-based Digilab will sell Axela's Ziplex system for gene and protein expression analysis and dotLab mX system for real-time immunoassays.

Axela to date has focused on providing protein analysis tools and services, and the addition of Xceed's Ziplex System for gene expression analysis will support its ambitions to speed the validation and clinical application of DNA, RNA, and protein biomarkers.

The deal combines Axela's multiplex protein biomarker testing capabilities and Xceed's Ziplex System for gene expression analysis, with a focus on multiplex diagnostic assays.

NPR reports the US Food and Drug Administration has approved a treatment for a genetic disorder that causes rapid aging.

Late-stage testing indicates the AstraZeneca and Oxford University SARS-CoV-2 vaccine can have up to 90 percent efficacy, the Associated Press reports.

ScienceInsider reports Nature Communications is reviewing a paper on mentorship following social media criticism arguing it is sexist.

In PLOS this week: method to account for sequencing errors in phylogenies, study of influenza A in Switzerland, and more.